Chiesi hands back gene therapy to uniQure – BioPharma Dive
FierceBiotech |
Chiesi hands back gene therapy to uniQure
BioPharma Dive Just months after uniQure N.V. announced it would not renew the market authorization for gene therapy Glybera in Europe, the company confirmed its partner Chiesi Farmaceutici is pulling out of another gene therapy agreement. The companies said Monday … Chiesi Ends Collaboration with uniQure on Hemophilia B Gene Therapy Candidate Uniqure from now on alone |
